Cancer Immunology

Webinar One

Release Date:  July 1, 2020, Expiration Date:  June 30, 2022

Learning Objectives:

  1. Participants will be able to describe the role of the immune system in cancer prevention.
  2. Participants will be able to understand how immunoediting leads to tumor escape mechanisms.
  3. Participants will be able to describe the three immune phenotypes that lead to cancer growth.

Target Audience:

This lecture is attended for primary care physicians, specialty physicians, physician assistants and nurses.


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 


The University of Florida College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Planning Committee Disclosure:

Conflict of interest information for the CME Advisory Committee members can be found on the following website:

Faculty Disclosure:

Dr. Rahman has disclosed that she has no relevant financial disclosures.  No one else in a position to control content has any financial relationships to disclose.

Bibliographic Sources:

Tian, X. Jia, K. Yuan, T. Pan, S. Jiang. Low-dose CT reconstruction via edge-preserving total variation regularization. Physics in Medicine and Biology, 56 (2011), pp. 5949-5967

Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565‐1570. doi:10.1126/science.1203486

Back to CME Series Main Page